Hayward, Calif.-based Zyomyx released its Protein Profiling Biochip System and a compatible array for human cytokines in February. Consisting of the Assay 1200™ automated workstation, the Scanner 100™ ...

Reverse phase protein array (RPPA) is a high-throughput technology that performs protein assays on thousands of samples simultaneously, including tissue and cell lysates, serum, plasma or other body ...

Cancer is one of the leading causes of death worldwide, affecting over 20 million individuals and killing 9.7 million in 2022 alone. Each of ~200 cancer types (and multiple subtypes) presents an ...

The protein-detection landscape has seen a number of advances in the last decade. Much of our knowledge of proteins has come from using ELISA, Western immunoblot, immunoprecipitation, and two-hybrid ...

Led by Lisa Kubiak, RN, the Athens, Georgia clinic now provides Genesis Regenerative’s non-cellular RPA product and an expanded digital platform. I have studied stem cells and the potential they offer ...

Scientists at Northwestern University have developed a new detection technology on the nanometer scale that could lead to the next generation of proteomic arrays and new methods for diagnosing ...

Antibody-based reverse-phase protein arrays to quantitatively analyze specific protein pathways and their activation states with large sample sets (tissue or cells). Approximately 290+ validated ...